How do you test for asbestosis?
Asbestosis, a chronic and debilitating lung disease, has long been a source of concern for individuals with occupational asbestos exposure. It is caused by breathing tiny asbestos fibres into the lungs when asbestos-containing material is cut or ground. The fibres scar the inside of the lungs, causing breathlessness.
Asbestosis is linked to a high risk of developing lung cancer and mesothelioma. Recognising the importance of early detection, healthcare professionals have developed diagnostic tools to identify asbestosis, allowing for timely intervention and the effective management of this complex disorder.
Understanding asbestosis
Common symptoms of asbestosis include shortness of breath, persistent cough, wheezing, and extreme tiredness. These early warning signs often appear decades after the initial asbestos exposure, making the condition particularly challenging to diagnose. In addition, individuals with a history of smoking or pre-existing lung conditions have a higher risk of developing asbestosis, further complicating the diagnostic process.
Physical examination findings
In the first instance, a physical examination of individuals with asbestosis may reveal a crackling sound while inhaling. A healthcare professional will use a stethoscope to listen carefully to the lungs. Additionally, some patients may exhibit clubbing of the fingertips, a condition characterised by the thickening and rounding of the nails, which can be a sign of underlying lung disease.
Chest imaging
The main way to diagnose asbestosis is by a thorough examination of the patient’s chest through imaging techniques. Chest X-rays can reveal characteristic patterns of interstitial fibrosis and pleural thickening, classic signs of the disease.
Computed Tomography (CT) scans
Computed tomography (CT) scans have emerged as invaluable diagnostic aids in the assessment of asbestosis. These imaging techniques provide a more detailed and precise view of the lung structures, allowing healthcare providers to identify early-stage parenchymal abnormalities and to distinguish between asbestos-related pleural changes and other conditions.
Magnetic Resonance Imaging (MRI)
Magnetic resonance imaging (MRI) can serve as a complementary diagnostic tool in cases where CT scans are inconclusive or contraindicated. MRI’s superior soft tissue contrast and the ability to detect subtle changes in lung architecture may prove beneficial in certain clinical scenarios, particularly when evaluating the extent and progression of asbestos-related lung disease.
Pulmonary function tests (lung function tests)
Alongside imaging techniques, pulmonary function tests play a crucial role in the diagnosis of asbestosis. These assessments measure lung health, providing healthcare professionals with information about respiratory impairment.
Spirometry
Spirometry, a fundamental pulmonary function test, measures the volume and rate of airflow during inhalation and exhalation. In individuals with asbestosis, spirometry may reveal a reduction in FVC, often with a normal or near-normal forced expiratory volume in one second (FEV1), indicating a restrictive ventilatory defect.
Diffusing capacity (DLCO)
The diffusing capacity for carbon monoxide (DLCO) test, provides healthcare professionals with a measure of the lungs’ ability to transfer oxygen from the alveoli to the bloodstream. In asbestosis, DLCO is reduced, reflecting the impaired gas exchange capacity of the damaged lung tissue.
Further evaluation
In some cases, healthcare providers may recommend more invasive diagnostic procedures.
Bronchoscopy
Bronchoscopy involves the insertion of a thin, flexible tube with a camera and biopsy tools into the patient’s airways. This technique allows healthcare professionals to visually inspect the lungs and obtain tissue samples for further analysis, which can be particularly useful in cases where the diagnosis remains uncertain.
Lung biopsy
In rare instances, a lung biopsy may be necessary to confirm asbestosis. This invasive procedure involves the removal of a small sample of lung tissue, which is then examined under a microscope for the presence of asbestos fibres and characteristic patterns of interstitial fibrosis.
Other diagnostic tests
While the core diagnostic methods outlined above form the foundation of asbestosis detection, healthcare professionals may also use other techniques to enhance the accuracy and comprehensiveness of the diagnostic process.
Bronchoalveolar Lavage (BAL)
Bronchoalveolar lavage (BAL) is a procedure in which a saline solution is instilled into the lungs and then aspirated, allowing for the collection and analysis of cells and other materials present in the alveoli. This can be used to quantify the presence and type of asbestos fibers in the lungs, providing valuable information to support the diagnosis of asbestosis.
Blood tests
Although blood tests do not directly diagnose asbestosis, they can be used to rule out other causes of the patient’s symptoms, such as autoimmune or infectious diseases. Healthcare professionals may order blood tests to ensure a comprehensive evaluation and eliminate alternative diagnoses.
Multidisciplinary approach
Diagnosing asbestosis requires a joint effort from healthcare professionals, including pulmonologists, radiologists, and occupational health specialists. By using the findings from all test results and procedures, experts can develop an understanding of the patient’s condition, allowing them to make an accurate diagnosis and tailor an appropriate treatment plan.
Challenges and limitations
Despite the availability of advanced diagnostic tools, identification of asbestosis can still present significant challenges. The long latency period between asbestos exposure and the onset of symptoms, as well as the potential for overlap with other respiratory conditions, can complicate the diagnostic process. Additionally, the interpretation of imaging findings and pulmonary function tests may require specialised expertise, underscoring the importance of referral to healthcare providers with experience in managing asbestos-related diseases.
Conclusion
Early detection of asbestosis is crucial, as timely intervention can significantly improve the patient’s quality of life, reduce symptoms of asbestosis and potentially slow the progression of the disease. By using all diagnostic tools and techniques available, healthcare professionals can work to identify asbestosis in its earliest stages, to start appropriate treatment and the management of associated complications.
Key takeaways
- Asbestosis is a chronic lung disease caused by long-term exposure to asbestos fibers, leading to scarring and impaired respiratory function
- Chest imaging, including X-rays and CT/HRCT scans, is the foundation of asbestosis diagnosis
- Pulmonary function tests, such as spirometry and DLCO, assess the degree of respiratory impairment
- Invasive procedures like bronchoscopy and lung biopsy may be necessary in some cases to confirm the diagnosis or rule out other conditions
- A multidisciplinary approach, involving healthcare professionals with expertise in asbestos-related diseases is crucial
- Early detection and ongoing monitoring are essential to reduce the progression of asbestosis and improve patient quality of life
Sources
- Asbestosis – Diagnosis & treatment – Mayo Clinic
- Asbestos Toxicity: Clinical Assessment – Tests – Environmental Medicine – ATSDR
- Asbestosis: Causes, Symptoms, Diagnosis & Treatment
- Asbestosis – NHS
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
What does NowPatient do?
NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.
Get started today and benefit from medication reminders, Get Treated Privately, NHS online pharmacy, GP appointment booking, Rx savings card, Drug Coupons, US drug savings programs, health conditions information, genetic testing, home test kits, BMI Risks, Type 2 Diabetes Risks, pollen meter, air quality monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.
UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.
US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
We do not provide any prescribing services or dispensing services in the United States.
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111